UCSD Partners with Cofactor Genomics to Improve Patient Outcomes in Metastatic Head and Neck Cancer
SAN DIEGO, Calif.– SEPTEMBER 15, 2020 – Physicians at the University of California, San Diego (UCSD) School of Medicine and Cofactor Genomics, the company bridging the precision medicine gap, today announced a partnership aimed at improving a physician’s ability to predict tum...
Cofactor Genomics Announces New U.S. Patent Granted for Predictive Immune Modeling Technology
SAN FRANCISCO, Calif. – August 20, 2020 – Cofactor Genomics, the company bridging the precision medicine gap, announced today that the United States Patent and Trademark Office (USPTO) has granted Patent No. 10636512 protecting the Company’s predictive immune modeling technolo...
Cofactor Genomics Awards Grants to Research Teams for New T Cell State Characterization Technology
San Francisco, CA – May 6, 2020 – Winners of Cofactor Genomics’ “Functional to FFPE” Grant Program were publicly announced today. Two projects from Dell Medical School at University of Texas and the University Hospital in Basel were chosen based on their potential to make a s...